(Q44407169)

2 December 2017

title

Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders (English)

1 reference

2 December 2017

Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300153

25 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300153

25 December 2023

1

Eric Hollander

1 reference

2 December 2017

5

Susan L McElroy

1 reference

2 December 2017

8

Charles B. Nemeroff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700713

25 December 2023

author name string

Patricia Wozniak

6

1 reference

2 December 2017

Katherine A. Tracy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700713

25 December 2023

Alan C. Swann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700713

25 December 2023

Emil F. Coccaro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700713

25 December 2023

Kenneth W. Sommerville

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700713

25 December 2023

language of work or name

English

0 references

publication date

2 April 2003

1 reference

full work available at URL

2 December 2017

https://www.nature.com/articles/1300153.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12700713

https://www.nature.com/articles/1300153.pdf

25 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300153

https://www.nature.com/articles/1300153

25 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300153

25 December 2023

published in

Neuropsychopharmacology

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

6

1 reference

2 December 2017

page(s)

1186-1197

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300153

2 December 2017

exact match

0 references

cites work

Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

The effects of phenytoin on impulsive and premeditated aggression: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

Fluoxetine and impulsive aggressive behavior in personality-disordered subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

A novel approach to assess inter-rater reliability in the use of the Overt Aggression Scale-Modified

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

New developments in impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

Pharmacotherapy for personality disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

Psychiatric aspects of impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

The deliberate self-harm syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

Valproate therapy for chronic, combat-induced posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

The effect of lithium on impulsive aggressive behavior in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

The long-term use of lithium in aggressive prisoners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

Factors associated with inpatient and outpatient treatment for children and adolescents with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Impulsive aggression: a behavior in search of clinical definition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Intermittent explosive disorder-revised: development, reliability, and validity of research criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Divalproex treatment of disruptive adolescents: a report of 10 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Remission of self-mutilation in a patient with borderline personality during risperidone therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Serotonergic function and self-injurious behavior in personality disorder patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Brain monoamines in aggression and sleep.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Measurement of inter-episode impulsivity in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Plasma insulin, tryptophan and serotonin levels during the glucose tolerance test among habitually violent and impulsive offenders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Divalproex sodium as a treatment for borderline personality disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300153

7 January 2021

Journal of Neuropsychiatry and Clinical Neurosciences

7

3

44

EF Coccaro

1991

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300153

Treatment of human aggression with major tranquilizers, antidepressants, and newer psychotropic drugs

25 December 2023

30

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300153

Communications in Behavioral Biology. Part A

25 December 2023

38

2

65

KE Moyer

1968

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300153

American Journal of Psychiatry

25 December 2023

48

148

1086

HV Szymanski

1991

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300153

25 December 2023

Identifiers

0 references

1 reference